Updated Date:
22 Dec 2025
Product Detail:
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
Shortage Status:
Anticipated
AUST R:
14435
Availability:
Available
Active Ingredient:
dantrolene sodium hemiheptahydrate
Reason:
Manufacturing
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 19 Jan 2026
To 27 Feb 2026
Management Action:
The sponsor is closely controlling supply. An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
